Analyst ratings, especially from reputable firms like Guggenheim, can significantly influence investor sentiment and stock prices. The initiation of coverage with a Buy rating and a high price target suggests a strong bullish outlook for Voyager Therapeutics, likely leading to increased investor interest and a rise in stock price in the short term.